Biotech Hub

Omicron live updates: New study suggests Pfizer-BioNTech vaccine may only partially protect against variant

Ergin Yalcin/iStock As the COVID-19 pandemic has swept the globe, more than 5.2 million people have died from the disease worldwide, including over 791,000 Americans, according to real-time data…

This advertisement has not loaded yet, but your article continues below. German drugmaker BioNTech SE’s executive on Wednesday said the interval between the second and third doses of its COVID-19…

BioNTech and Pfizer said that two vaccine doses resulted in significantly lower neutralizing antibodies but that a third dose of their COVID-19 vaccine increased the neutralizing antibodies by a…

This advertisement has not loaded yet, but your article continues below. BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was shown to generate a neutralizing effect…

Read more about BioNTech, Pfizer say test shows 3 doses of vaccine neutralise Omicron on Devdiscourse

“The companies believe that vaccinated individuals may still be protected against severe forms of the disease,” they added.

Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron variant, the companies warned Wednesday, but stressed it was ‘still effective’ after a third…

Pfizer, BioNTech Say Third Dose Neutralizes Omicron Variant

Booster being developed for new variant could be ready by March, vaccine makers say – Click the link for more details